Mr. Speaker, my question is for the Minister of Industry. Despite the unsettling effect that his hasty, irresponsible statement about reviewing the drug patent legislation has had, the Minister of Industry reiterated yesterday his intention of going ahead with a review of the legislation. Already, the review is jeopardizing important investments in Quebec.
Does the minister intend to follow up on the request of his Quebec colleague and put to rest his concerns, as well as those of the multinational which this week decided, further to Ottawa's hasty announcement to reopen Bill C-91, the drug patent legislation, that it was holding off on a $50 million investment in Quebec?